Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors

Experimental Eye Research

Volumn 62, Issue 1, 1996, Pages 1-10

  Schmidt Erfurth, Ursula ^a,b   Flotte, Thomas J ^a   Gragoudas, Evangelos S ^b   Schomacker, Kevin ^a   Birngruber, Reginald ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

benzoporphyrin derivative; in vivo; intraocular tumors; low density lipoprotein; photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; THROMBOSIS; TUMOR NECROSIS; ULTRASTRUCTURE; UVEA MELANOMA;

EID: 0029916830     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0001     Document Type: Article

References (43)

1. Allison, R. A., Waterfield, E., Richter, A. M. and Levy, J. G. (1990). The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins and its biodistribution. Photochem. Photobiol. 52, 501-7.
2. Allison, R. A., Waterfield, E., Richter, A. M. and Levy, J. G. (1991). The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem. Photobiol. 54, 709-15.
3. Augsburger J. J., Gamel, J. W., Sardi, V. F., Greenberg, R. A., Shields, J. A. and Brady, L. W. (1985). Enucleation versus cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch. Ophthalmol 104, 655-61.
4. Aveline, B., Hasan, T. and Redmond, R. W. (1994). Photophysical and Photosensitizing Properties of Benzoporphyrin Derivative Monoacid Ring A (BPD-MA). Photochem. Photobiol. 59, 329-35.
5. Bernal, S. D., Lampidis, T. J., Summermayer, I. C. and Chen, L. B. (1982). Rhodamine 125 selectively reduces clonal growth of carcinoma cells in vivo. Science 218, 1117-19.
6. Fielding, P. E., Vlodevsky, I., Gospodarowicz, D. and Fielding, C.J. (1979). Effect of contact inhibition on the regulation of cholesterol metabolism in cultured vascular endothelial cells. J. biol. Chem. 254, 749-55.
7. Franklin, N. A. P., van Delft, J. C., Dubbelman, T. M. A. R., Wolff-Runendaal, D., de Oosterhuis, J. A., Star, W. M. and Marijuisen, H. P. A. (1985). Hematoporphyrin derivative photoradiation treatment of experimental malignant melanoma in the anterior eye chamber of the rabbit. Curr. Eye Res., 4, 641.
8. Gal, D., MacDonald, V. L., Porter, J. C. and Stimpson, E. R. (1981). Cholesterol metabolism in cancer cells in monolayer culture. Ill low density lipoprotein metabolism. Int. J. Cancer 28, 315-19.
9. Garretson, B. R., Robertson, D. M. and Earle, J. D. (1987). Choroidal melanoma treatment with iodine 125 brachytherapy. Arch. Ophthalmol. 105, 1394-7.
10. Goff, B., Bamberg, M. and Hasan, T. (1991). Photoimmunotherapy of human ovarian cancer cells ex vivo. Cancer Res. 51, 4762-7.
11. Gomer, C. J., Rucker, N. and Murphree, A. L. (1988). Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res. 48, 4539-42.
12. Gomer, C. J. (1991). Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol. 34, 1093-107.
13. Gragoudas, E. S., Seddon, J. M., Egan, K. et al. (1987). Long term results of proton beam irradiated uveal melanomas. Am. J. Ophthalmol. 94, 349-53.
14. Hasan, T. (1992). Photosensitizer delivery mediated by micromolecular carrier systems. In Photodynamic Therapy: Basic Principles and Clinical Applications. (Eds Henderson, B. and Dougherty, T.). Pp. 187-200. Marcel Dekker.
15. Hasan, T. and Parrish, J. A. (1995). Photodynamic Therapy of Cancer. In Cancer Research Fourth Edition. (Ed. Holland, J. F.) Williams & Wilkins, in press.
16. Henderson, B. W. and Dougherty, T. J. (1992). How does photodynamic therapy work? Photochem. Photobiol. 55, 145-57.
17. Ho, Y. K., Smith, C. R., Brown, M. S. and Goldstein, J. L. (1979). Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 56, 1099-114.
18. Jiang, F. N., Richter, A. M., Jain, A. K., Levy, J. G. and Smits, C. (1993). Biodistribution of a benzoporphyrin derivate-monoclonal antibody conjugate in A549 tumor-bearing mole mice. Biotechnol. Therapeutics 4, 43-61.
19. Jori, G. (1990). Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy. Lasers Med Sci. 5, 115-20.
20. Jori, G. (1992). Low density lipoproteins-liposome delivery systems for tumor photosensitizers in vivo. In Photodynamic Therapy: Basic Principles and Clinical Applications. (Eds Henderson, B. W. and Dougherty, T. J.) Pp. 173-186. Marcel Dekker.
21. Lui, H., Kollias, N., Wimberly, J., Hruza, L. and Anderson, R. R. (1993). Photodynamic therapy of malignant skin tumors with BDP-MA-preliminary observations of tumor response and photosensitivity of normal skin. In Lasers in Dermatology and Plastic Surgery. SPIE 1876B-37, Los Angeles.
22. Mew, D., Wat, C. K., Towers, G. H. N. and Levy, J. G. (1983). Photoimmunotherapy : treatment of animal tumors with tumor-specific monoclonal antibodyhematoporphyrin conjugates. J. Immunol. 130, 1473-7.
23. Murphree, A. L., Cote, M. and Gomer, C. J. (1987). The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem. Photobiol. 46, 919-23.
24. Nelson, J. S., Liaw, L.-H. and Berns, M. W. (1987). Tumor destruction in photodynamic therapy. Photochem. Photobiol. 46, 829-35.
25. Okunaka, T., Eckhauser, M., Kato, H., Bornaminio, A., Yamamoto, H., Alozawa, K., Serasna, M. and Koehler, K. A. (1992). Correlation between photodynamic efficacy of differing porphyrins and membrane partitioning behaviour. Lasers. Surg. Med. 12, 98-103.
26. Panagopoulos, J., Svitra, P., Puliafito, C. and Gragoudas, E. (1989). Photodynamic therapy for experimental intraocular melanoma using chloraluminum sulfonated phthalocyanine. Arch. Ophthalmol. 107, 886-90.
27. 3H-BPD-MA), a new potent photosensitizer in normal and tumor-bearing mice. J. Photochem. Photobiol 5, 231-44.
28. Richter, A. M., Kelly, B., Chow, J., Lin, D. J., Towes, G. H. N., Dolphin, D. and Levy, J. G. (1987). Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J. Natl. Cancer Inst. 79, 1327-32.
29. Richter, A. M., Waterfield, E., Jain, A. K., Allison, B., Sternberg, E. D., Dolphin, D. and Levy, J. G. (1991a). Photosensitizing potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumor model. Br. J. Cancer 63, 87-93.
30. Richter, A. M., Yip, S., Waterfield, E., Logan, P. M., Slonecker, C. E. and Levy, J. G. (1991b). Mouse skin photosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation. Photochem. Photobiol. 53, 281-6.
31. Roberts, W. G. and Hasan, T. (1993). Tumor-secreted vascular permeability factor influences photosensitizer uptake. Cancer Res. 53, 1-5.
32. Roberts, W. G. and Hasan, T. (1992). Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 52, 924-30.
33. Rudel, L. L., Lee, J. A., Morris, M. D. and Felts, J. M. (1974). Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. Biochem. J. 139, 89-95.
34. Schmidt-Erfurth, U., Hasan, T., Gragoudas, E., Michaud, N., Flotte, T. J. and Birngruber, R. (1994). Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101, 1953-61.
35. Schuittmaker, J. J., van Best, J. A., van Delft, J. L., Dubbelman, M. A. R., Oosterhuis, J. A. and de Wolff-Ronendaal, D. (1990). Bacteriochlorin a, a new photosensitizer in photodynamic therapy. Invest. Ophthalmol. Vis. Sci. 31, 1444-50.
36. Seddon, J. M., Gragoudas, E. S., Albert, D. M., Hsieh, C. C., Povilogianis, L. and Friedenberg, G. R. (1985). Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am. J. Ophthalmol. 99, 202-90.
37. Sery, T. W., Shields, J. A., Augsburger, J. J. and Shah, B. G. (1987). Photodynamic therapy of human ocular cancer. Ophthalmic Surg. 18, 413-18.
38. Tse, D. T., Dutton, J. J., Weingeist, T. A., Hernisen, V. M. and Kersten, R. C. (1984). Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch. Ophthalmol. 102, 833.
39. van Huisbergh, V. W. L., Havekes, L., Emeis, J. J., van Garven, E., Scheffer, M. (1983). Low density lipoprotein metabolism by endothelial cells from umbilical cord arteries and veins. Arteriosclerosis 3, 547-59.
40. Vitols, S., Gahrton, G., Bjorkhol, M. and Peterson, C. (1985). Hypocholesterolemia in malignancy due to elevated LDL receptor activity in tumor cells. Lancet ii, 1150-4.
41. Weishaupt, K. R., Gomer, C. J. and Dougherty, T. J. (1976). Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36, 2326-9.
42. West, C. M. L., West, D. C., Kimmar, S. and Moore, J. C. (1990). A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. Int. J. Radiat. Biol. 58, 145-56.
43. Zimmerman, L. E., McLean, I. W. and Foster, W. D. (1978). Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br. J. Ophthalmol. 62, 420-5.